Comparison between short-term Renal Haemodynamic Effects of Propranolol and Nadolol in Essential Hypertension: A Crossover Study
- 1 August 1984
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 67 (2) , 243-248
- https://doi.org/10.1042/cs0670243
Abstract
The effect of 4-6 wk treatment with propranolol and nadolol on effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) was studied, in 14 patients with essential hypertension, in single blind, random and cross-over design. Both drugs caused comparable effective lowering of pulse and blood pressure. When taken as the 1st drug, propranolol caused significant reduction in ERPF and GFR and a rise in filtration fraction (FF) and renal vascular resistance (RVR), whereas nadolol caused distinct rise in ERPF and a fall in FF and RVR, but GFR remained unchanged. These hemodyamic effects were reduced when propranolol was given immediately after the withdrawal of nadolol and were obviated when nadolol followed propranolol therapy. This suggested a carry-over effect of the 1st drug into the 2nd phase of treatment. With short term therapy in essential hypertension, propranolol apparently has a renal vasoconstrictor and nadolol a vasodilator effect.This publication has 6 references indexed in Scilit:
- The long-term effect of propranolol therapy on renal functionThe American Journal of Medicine, 1979
- EFFECT OF SOME BETA-ADRENERGIC BLOCKING-DRUGS ON RENAL BLOOD-FLOW IN DOGS1977
- RENAL-FUNCTION FOLLOWING A SINGLE DOSE OF PINDOLOL IN HYPERTENSIVE PATIENTS WITH VARYING DEGREES OF IMPAIRMENT OF RENAL-FUNCTION1977
- beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.Circulation Research, 1976
- Immediate Hemodynamic Effects of Beta-Adrenergic Blockade with Propranolol in Normotensive and Hypertensive ManCirculation, 1968
- Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fieldsAmerican Heart Journal, 1967